About
Lantheus Holdings Inc (NASDAQ:LNTH) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 23 2026
Lantheus to Host First Quarter 2026 Earnings Conference Call and Webcast on May 7, 2026, at 8:00 a.m. Eastern Time
Mar 17 2026
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
Mar 6 2026
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
Mar 2 2026
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
Feb 26 2026
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Financials
Revenue
$1.54 B
Market Cap
$4.95 B
P/E Ratio
22.32
EPS
3.41
Google Übersetzer